Evidence map›Paper›PMID 33011803›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Patient-reported Reasons for Stopping Care or Switching Clinics in Zambia: A Multisite, Regionally Representative Estimate Using a Multistage Sampling-based Approach in Zambia.

Izukanji Sikazwe, Ingrid Eshun-Wilson, Kombatende Sikombe, Laura K Beres, Paul Somwe, Aaloke Mody, Sandra Simbeza, Chama Bukankala, David V Glidden, Lloyd B Mulenga and 5 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06803316 (Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06803316 completednot on this mapstarted 2022, after this paper: background citation

Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia

Typeobservational_patient_registrySponsorCentre for Infectious Disease Research in ZambiaRan2022 to 2025Enrolled658ConditionsHIV Antiretroviral Therapy (ART) Adherence
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Incidence of Health Facility Switching and Associations With HIV Viral Rebound Among Persons on Antiretroviral Therapy in Uganda: A Population-based Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Izukanji SikazweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Ingrid Eshun-WilsonWashington University in St Louis, St Louis, Missouri, USA.
Kombatende SikombeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-8187-8661
Laura K BeresJohns Hopkins University, Baltimore, Maryland, USA.
Paul SomweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Aaloke ModyWashington University in St Louis, St Louis, Missouri, USA.ORCID 0000-0003-3787-365X
Sandra SimbezaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Chama BukankalaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
David V GliddenWashington University in St Louis, St Louis, Missouri, USA.
Lloyd B MulengaMinistry of Health, Lusaka, Zambia.
Nancy PadianUniversity of California Berkeley, Berkeley, California, USA.ORCID 0000-0003-1046-2287
Peter EhrenkranzBill and Melinda Gates Foundation, Seattle, Washington, USA.
Carolyn Bolton-MooreUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Charles B HolmesCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Elvin H GengWashington University in St Louis, St Louis, Missouri, USA.
Centre for Infectious Disease Research in Zambia · ZMWashington University in St. Louis · USGates Foundation · USJohns Hopkins University · USMinistry of Health · ZMUniversity of Alabama at Birmingham · USUniversity of California, Berkeley · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
Bill and Melinda Gates Foundation OPP1105071NCATS NIH HHS KL2 TR002346NIAID NIH HHS K24 AI134413NIAID NIH HHS P30 AI094189NIH HHS P30 AI027763
6 · The paper itself

Abstract

backgroundUnderstanding patient-reported reasons for lapses of retention in human immunodeficiency virus (HIV) treatment can drive improvements in the care cascade. A systematic assessment of outcomes among a random sample of patients lost to follow-up (LTFU) from 32 clinics in Zambia to understand the reasons for silent transfers and disengagement from care was undertaken.

methodsWe traced a simple random sample of LTFU patients (>90 days from last scheduled visit) as determined from clinic-based electronic medical records from a probability sample of facilities. Among patients found in person, we solicited reasons for either stopping or switching care and predictors for re-engagement. We coded reasons into structural, psychosocial, and clinic-based barriers.

resultsAmong 1751 LTFU patients traced and found alive, 31% of patients starting antiretroviral therapy (ART) between 1 July 2013 and 31 July 2015 silently transferred or were disengaged (40% male; median age, 35 years; median CD4 level, 239 cells/μL); median time on ART at LTFU was 480 days (interquartile range, 110-1295). Among the 544 patients not in care, median prevalences for patient-reported structural, psychosocial, and clinic-level barriers were 27.3%, 13.9%, and 13.4%, respectively, and were highly variable across facilities. Structural reasons, including, "relocated to a new place" were mostly cited among 289 patients who silently transferred (35.5%). We found that men were less likely to re-engage in care than women (odds ratio, .39; 95% confidence interval, .22-.67; P = .001).

conclusionsEfforts to improve retention of patients on ART may need to be tailored at the facility level to address patient-reported barriers.

Indexed as

Anti-HIV AgentsHIV InfectionsAdultElectronic Health RecordsFemaleHumansLost to Follow-UpMalePatient Reported Outcome MeasuresZambiaAnti-HIV AgentsdisengagementHIVreasonsretentionZambia

Identifiers

PMID33011803
PMCPMC8492131
OpenAlexW3089623336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.